Immunohistochemistry: Peripheral Node Addressin Antibody (MECA-79) - Non-Recombinant Monoclonal [NB100-77673] - Local release of anti-IL-6 from IMB suppresses LN fibrosis. The skin allografts were harvested at 7 days post-transplantation. (A-i) Lymphatic vessel expansion (Lyve-1+) and HEV elongation (MECA79+) were similar between all groups. (A-ii,iii) Dense staining of collagen I was seen in DLNs harvested from control and GelMA group compared to those from GelMA/anti-IL-6 group. (representative images from 4 different mice per group).

Immunohistochemistry: Peripheral Node Addressin Antibody (MECA-79) - Non-Recombinant Monoclonal [NB100-77673] - Local release of anti-IL-6 from IMB suppresses LN fibrosis. The skin allografts were harvested at 7 days post-transplantation. (A-i) Lymphatic vessel expansion (Lyve-1+) and HEV elongation (MECA79+) were similar between all groups. (A-ii,iii) Dense staining of collagen I was seen in DLNs harvested from control and GelMA group compared to those from GelMA/anti-IL-6 group. (representative images from 4 different mice per group).

Immunohistochemistry: Peripheral Node Addressin Antibody (MECA-79) - Non-Recombinant Monoclonal [NB100-77673] - Local release of anti-IL-6 from IMB suppresses LN fibrosis. The skin allografts were harvested at 7 days post-transplantation. (A-i) Lymphatic vessel expansion (Lyve-1+) and HEV elongation (MECA79+) were similar between all groups. (A-ii,iii) Dense staining of collagen I was seen in DLNs harvested from control and GelMA group compared to those from GelMA/anti-IL-6 group. (representative images from 4 different mice per group).

Immunohistochemistry: Peripheral Node Addressin Antibody (MECA-79) - Non-Recombinant Monoclonal [NB100-77673] - Local release of anti-IL-6 from IMB suppresses LN fibrosis. The skin allografts were harvested at 7 days post-transplantation. (A-i) Lymphatic vessel expansion (Lyve-1+) and HEV elongation (MECA79+) were similar between all groups. (A-ii,iii) Dense staining of collagen I was seen in DLNs harvested from control and GelMA group compared to those from GelMA/anti-IL-6 group. (representative images from 4 different mice per group).